PlexusDx tirzepatide injections come from licensed 503A compounding pharmacies using the same active pharmaceutical ingredient as Mounjaro, delivering equivalent efficacy
Rather than focusing on a single biological target, newer molecules increasingly aim to model the interconnected nature of human physiology
Phase 2 data showed 24.2% average weight loss at 48 weeks
This product is not a drug, food, or cosmetic and may not be misbranded, misused or mis-labled as a drug, food or cosmetic
Weight loss can cause bone loss for anyone
The new blockbuster obesity drugs, made famous by Ozempic, are collectively known as GLP-1 agonists, for the hormone they mimic in the body: glucagon-like peptide 1